High JAM3 expression and unmethylated JAM3 DNA are favourite survival predictors for patients with CCA, suggesting that JAM3 may be a non‐invasive biomarker for the diagnosis and prognosis of CCA. This evidence concerns the gene JAM3 and cholangiocarcinoma.